Literature DB >> 34320405

A quantitative map of human primary microRNA processing sites.

Kijun Kim1, S Chan Baek1, Young-Yoon Lee1, Carolien Bastiaanssen1, Jeesoo Kim1, Haedong Kim1, V Narry Kim2.   

Abstract

Maturation of canonical microRNA (miRNA) is initiated by DROSHA that cleaves the primary transcript (pri-miRNA). More than 1,800 miRNA loci are annotated in humans, but it remains largely unknown whether and at which sites pri-miRNAs are cleaved by DROSHA. Here, we performed in vitro processing on a full set of human pri-miRNAs (miRBase version 21) followed by sequencing. This comprehensive profiling enabled us to classify miRNAs on the basis of DROSHA dependence and map their cleavage sites with respective processing efficiency measures. Only 758 pri-miRNAs are confidently processed by DROSHA, while the majority may be non-canonical or false entries. Analyses of the DROSHA-dependent pri-miRNAs show key cis-elements for processing. We observe widespread alternative processing and unproductive cleavage events such as "nick" or "inverse" processing. SRSF3 is a broad-acting auxiliary factor modulating alternative processing and suppressing unproductive processing. The profiling data and methods developed in this study will allow systematic analyses of miRNA regulation.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DGCR8; DROSHA; Microprocessor; SRSF3; microRNA; pri-miRNA processing

Year:  2021        PMID: 34320405     DOI: 10.1016/j.molcel.2021.07.002

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  9 in total

1.  Tendon-Specific Dicer Deficient Mice Exhibit Hypoplastic Tendon Through the Downregulation of Tendon-Related Genes and MicroRNAs.

Authors:  Takenori Omoto; Dilimulati Yimiti; Yohei Sanada; Minoru Toriyama; Chenyang Ding; Yuta Hayashi; Yasunari Ikuta; Tomoyuki Nakasa; Masakazu Ishikawa; Masayuki Sano; Minjung Lee; Takayuki Akimoto; Chisa Shukunami; Shigeru Miyaki; Nobuo Adachi
Journal:  Front Cell Dev Biol       Date:  2022-06-14

2.  Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis.

Authors:  Michael Hecker; Brit Fitzner; Elena Putscher; Margit Schwartz; Alexander Winkelmann; Stefanie Meister; Ales Dudesek; Dirk Koczan; Peter Lorenz; Nina Boxberger; Uwe Klaus Zettl
Journal:  EBioMedicine       Date:  2022-05-10       Impact factor: 11.205

Review 3.  MicroRNAs as therapeutic targets in cardiovascular disease.

Authors:  Bernhard Laggerbauer; Stefan Engelhardt
Journal:  J Clin Invest       Date:  2022-06-01       Impact factor: 19.456

4.  Intramolecular ligation method (iLIME) for pre-miRNA quantification and sequencing.

Authors:  Minh Ngoc Le; Cong Truc Le; Tuan Anh Nguyen
Journal:  RNA       Date:  2022-04-29       Impact factor: 5.636

Review 5.  Reexamining assumptions about miRNA-guided gene silencing.

Authors:  Audrius Kilikevicius; Gunter Meister; David R Corey
Journal:  Nucleic Acids Res       Date:  2022-01-25       Impact factor: 16.971

6.  High-throughput in vitro processing of human primary microRNA by the recombinant microprocessor.

Authors:  Kijun Kim; V Narry Kim
Journal:  STAR Protoc       Date:  2022-01-06

7.  Flexible pri-miRNA structures enable tunable production of 5' isomiRs.

Authors:  Xavier Bofill-De Ros; Zhenyi Hong; Ben Birkenfeld; Sarangelica Alamo-Ortiz; Acong Yang; Lisheng Dai; Shuo Gu
Journal:  RNA Biol       Date:  2021-12-31       Impact factor: 4.652

8.  Double-stranded RNA induction asa potential dynamic biomarkerfor DNA-demethylating agents.

Authors:  Minjeong Kang; Raisa Kharbash; Ja Min Byun; Jaemin Jeon; Ahsan Ausaf Ali; Doyeong Ku; Jimin Yoon; Yongsuk Ku; Jooyeon Sohn; Seung-Jae V Lee; Dong-Yeop Shin; Youngil Koh; Sung-Soo Yoon; Junshik Hong; Yoosik Kim
Journal:  Mol Ther Nucleic Acids       Date:  2022-07-21       Impact factor: 10.183

9.  Effects of acupuncture treatment on microRNAs expression in ovarian tissues from Tripterygium glycoside-induced diminished ovarian reserve rats.

Authors:  Ge Lu; Yao-Yao Zhu; Hong-Xiao Li; Yao-Li Yin; Jie Shen; Mei-Hong Shen
Journal:  Front Genet       Date:  2022-09-21       Impact factor: 4.772

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.